Essais liés2clinical trials
VilleJerusalemlocalisation
PaysIsraellocalisation
SourcelocaleCSV/MySQL

Informations

centre

Import ClinicalTrials.gov

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Sevasemten 10 mg Myopathies Phase 2 NCT05291091 Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) ACTIVE_NOT_RECRUITING
Sevasemten Myopathies Phase 2 NCT06066580 MESA — Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy ENROLLING_BY_INVITATION